المؤلفون: Zijlker LP; Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Chen H; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore Hospital, Sydney, NSW, Australia.; The Mater Hospital, Sydney, NSW, Australia., Gonzalez M; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Pennington TE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore Hospital, Sydney, NSW, Australia.; The Mater Hospital, Sydney, NSW, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Ferguson P; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia., Rawson R; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia., Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; The Mater Hospital, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Nieweg O; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore Hospital, Sydney, NSW, Australia.; The Mater Hospital, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. alexander.vanakkooi@melanoma.org.au.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. alexander.vanakkooi@melanoma.org.au.; Royal Prince Alfred Hospital, Sydney, NSW, Australia. alexander.vanakkooi@melanoma.org.au.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2024 Aug; Vol. 31 (8), pp. 5324-5330. Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/surgery , Melanoma*/pathology , Melanoma*/drug therapy , Melanoma*/mortality , Lymph Node Excision* , Neoadjuvant Therapy* , Neoplasm Staging*, Humans ; Female ; Male ; Middle Aged ; Follow-Up Studies ; Survival Rate ; Aged ; Skin Neoplasms/pathology ; Skin Neoplasms/surgery ; Skin Neoplasms/drug therapy ; Postoperative Complications ; Retrospective Studies ; Adult ; Australia ; Prognosis ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Immune Checkpoint Inhibitors/therapeutic use

المؤلفون: Zijlker LP; Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Chen H; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore Hospital, Sydney, NSW, Australia.; The Mater Hospital, Sydney, NSW, Australia., Gonzalez M; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Pennington TE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore Hospital, Sydney, NSW, Australia.; The Mater Hospital, Sydney, NSW, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Ferguson P; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia., Rawson R; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia., Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; The Mater Hospital, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Nieweg O; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; The Mater Hospital, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore Hospital, Sydney, NSW, Australia.; The Mater Hospital, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia., van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. alexander.vanakkooi@melanoma.org.au.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. alexander.vanakkooi@melanoma.org.au.; Royal Prince Alfred Hospital, Sydney, NSW, Australia. alexander.vanakkooi@melanoma.org.au.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2024 Aug; Vol. 31 (8), pp. 4954-4955.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/surgery , Melanoma*/pathology , Melanoma*/drug therapy , Neoadjuvant Therapy* , Lymph Node Excision*, Humans ; Neoplasm Staging ; Skin Neoplasms/pathology ; Skin Neoplasms/surgery ; Survival Rate ; Prognosis ; Australia

المؤلفون: Maher NG; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Prosser N; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia., Aivazian K; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Colebatch AJ; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Ferguson PM; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Karim RZ; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., McKenzie CA; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Rawson RV; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Lo SN; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Scolyer RA; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. Electronic address: richard.scolyer@health.nsw.gov.au.

المصدر: Pathology [Pathology] 2023 Oct; Vol. 55 (6), pp. 800-805. Date of Electronic Publication: 2023 Jun 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE

مواضيع طبية MeSH: Skin Neoplasms*/pathology , Carcinoma, Basal Cell*/diagnosis , Carcinoma, Basal Cell*/pathology, Humans ; Reproducibility of Results ; Observer Variation

المؤلفون: Nguyen MA; Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Colebatch AJ; Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Van Beek D; Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Tierney G; Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Gupta R; Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Cooper WA; Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; School of Medicine, Western Sydney University, Sydney, NSW, Australia. Electronic address: wendy.cooper@health.nsw.gov.au.

المصدر: Pathology [Pathology] 2023 Aug; Vol. 55 (5), pp. 596-609. Date of Electronic Publication: 2023 May 26.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/genetics , Neoplasms*/pathology , Breast Neoplasms* , Carcinoma*, Humans ; Female ; Receptor, trkA/genetics ; Pathologists ; Oncogene Proteins, Fusion/genetics ; Gene Fusion

المؤلفون: Patel RM; Departments of Pathology and Dermatology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address: rajivpat@med.umich.edu., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

المصدر: Pathology [Pathology] 2023 Mar; Vol. 55 (2), pp. 167-168. Date of Electronic Publication: 2023 Jan 10.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/diagnosis , Melanoma*/pathology , Skin Neoplasms*/diagnosis , Skin Neoplasms*/pathology, Humans

المؤلفون: Maher NG; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. Electronic address: richard.scolyer@health.nsw.gov.au., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

المصدر: Pathology [Pathology] 2023 Mar; Vol. 55 (2), pp. 169-177. Date of Electronic Publication: 2022 Dec 29.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE

مواضيع طبية MeSH: Nevus, Epithelioid and Spindle Cell*/genetics , Nevus, Epithelioid and Spindle Cell*/pathology , Skin Neoplasms*/genetics , Skin Neoplasms*/pathology, Humans ; Dysplastic Nevus Syndrome/genetics ; Dysplastic Nevus Syndrome/pathology ; Genomics ; Proto-Oncogene Proteins B-raf/genetics

المؤلفون: Newell F; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Johansson PA; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Nones K; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Lakis V; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Pritchard AL; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Department of Genetics and Immunology, Division of Biomedical Science, University of the Highlands and Islands, Inverness, Scotland, United Kingdom., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Kazakoff SH; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Koufariotis LT; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Wood S; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Leonard C; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Law MH; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia., Brooks KM; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Broit N; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Q-Gen Cell Therapeutics, Brisbane, Queensland, Australia., Palmer JM; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Couts KL; Center for Rare Melanomas, University of Colorado Cancer Center, Aurora, Colorado., Vergara IA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Royal North Shore Hospital, St Leonards, New South Wales, Australia., Barbour AP; Diamantina Institute, The University of Queensland, Brisbane, Queensland, Australia., Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Shivalingam B; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Department of Neurosurgery, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.; Department of Neurosurgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Robinson WA; Center for Rare Melanomas, University of Colorado Cancer Center, Aurora, Colorado., Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Royal North Shore Hospital, St Leonards, New South Wales, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Mann GJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia., Pearson JV; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Waddell N; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Hayward NK; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

المصدر: Cancer discovery [Cancer Discov] 2022 Dec 02; Vol. 12 (12), pp. 2856-2879.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/pathology , Skin Neoplasms*/genetics , Skin Neoplasms*/metabolism, Humans ; Ultraviolet Rays ; Genomics ; Mutation ; Melanoma, Cutaneous Malignant

SCR Disease Name: Uveal melanoma

المؤلفون: Colebatch AJ; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Paver EC; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia., Vergara IA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Scolyer RA; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. Electronic address: richard.scolyer@health.nsw.gov.au.

المصدر: Pathology [Pathology] 2022 Aug; Vol. 54 (5), pp. 533-540. Date of Electronic Publication: 2022 Mar 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/diagnosis , Melanoma*/genetics , Melanoma*/pathology , Nevus, Epithelioid and Spindle Cell*/genetics , Nevus, Pigmented*/diagnosis , Nevus, Pigmented*/genetics , Nevus, Pigmented*/pathology , Skin Neoplasms*/diagnosis , Skin Neoplasms*/genetics , Skin Neoplasms*/pathology, Cell Transformation, Neoplastic/genetics ; Humans ; Mutation ; Promoter Regions, Genetic ; Proto-Oncogene Proteins B-raf/genetics

المؤلفون: Colebatch AJ; Melanoma Institute Australia.; Faculty of Medicine and Health.; NSW Health Pathology.; Royal Prince Alfred Hospital., Adhikari C; Melanoma Institute Australia.; Faculty of Medicine and Health.; NSW Health Pathology., Diefenbach RJ; Faculty of Medicine, Health, and Human Sciences, Macquarie University, Sydney, NSW, Australia., Rawson RV; Melanoma Institute Australia.; Faculty of Medicine and Health.; NSW Health Pathology.; Royal Prince Alfred Hospital., Ferguson PM; Melanoma Institute Australia.; Faculty of Medicine and Health.; NSW Health Pathology.; Royal Prince Alfred Hospital., Rizos H; Melanoma Institute Australia.; Faculty of Medicine, Health, and Human Sciences, Macquarie University, Sydney, NSW, Australia., Long GV; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, The University of Sydney.; Royal North Shore and Mater Hospitals., McCarthy SW; Melanoma Institute Australia.; Faculty of Medicine and Health.; NSW Health Pathology.; Royal Prince Alfred Hospital., Thompson JF; Melanoma Institute Australia.; Faculty of Medicine and Health.; Royal Prince Alfred Hospital., Wilmott JS; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, The University of Sydney., Scolyer RA; Melanoma Institute Australia.; Faculty of Medicine and Health.; Charles Perkins Centre, The University of Sydney.; NSW Health Pathology.; Royal Prince Alfred Hospital.

المصدر: The American journal of surgical pathology [Am J Surg Pathol] 2022 Aug 01; Vol. 46 (8), pp. 1048-1059. Date of Electronic Publication: 2022 Apr 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7707904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-0979 (Electronic) Linking ISSN: 01475185 NLM ISO Abbreviation: Am J Surg Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/pathology , Nevus*/pathology , Nevus, Blue*/genetics , Nevus, Blue*/pathology , Skin Neoplasms*/pathology, Follow-Up Studies ; Humans

المؤلفون: Potter AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia., Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Cooper WA; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Western Sydney University, Campbelltown, NSW, Australia., Gupta R; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., O'Toole S; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Western Sydney University, Campbelltown, NSW, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia., Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. Electronic address: richard.scolyer@health.nsw.gov.au.

المصدر: Pathology [Pathology] 2022 Aug; Vol. 54 (5), pp. 526-532. Date of Electronic Publication: 2022 Mar 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/diagnosis , Melanoma*/genetics , Melanoma*/pathology , Neoplasms, Second Primary* , Skin Neoplasms*/diagnosis , Skin Neoplasms*/genetics , Skin Neoplasms*/pathology, DNA Mutational Analysis/methods ; Humans ; Mutation ; Pathologists ; Proto-Oncogene Proteins B-raf/genetics ; Melanoma, Cutaneous Malignant